Dow Corning Expands Healthcare Portfolio with New QP1 Silicone Elastomer Bases for Wider Processing Flexibility

Published Feb 12, 2013

Anaheim, Calif.– Dow Corning, a global leader in silicones, silicon-based technology and innovation for the healthcare industry, today announced here at MD&M West (Hall D, Booth #1751) Dow Corning®QP1 Silicone Elastomers, a new silicone technology for the company’s high consistency rubber (HCR) product line. Well suited for medical tubing and other extruded applications – including short-term implants – the one-part QP1 HCR bases are supplied uncatalyzed to offer medical device OEMs and fabricators processing flexibility, enabling them to choose the most suitable formulation for each application. The materials provide high strength and can be platinum catalyzed using Dow Corning masterbatches. Alternatively, the products can be cured using a peroxide initiated system.